Our Pacesetter ™ (FDA class 1 exempt device) automates, at last, the only manual step: enabling section mounting on slides directly from the microtome.
US total Market size potential $1.3 B ; Worldwide > $3 B
Only One potential Competitor at 10x our price
Developed 5 Units running Beta Tests; first commercial sales late 2016
Extensive Proprietary Portfolio of I.P. is fully owned by the company
Experienced Management Team